ASH 2014: Targeted therapies in a crowded cancer field
This article was originally published in Scrip
Executive Summary
Targeted therapies for hematologic malignancies showed a wide range of response rates when abstracts for presentations during the 56th American Society of Hematology (ASH) Annual Meeting and Exposition were released on 6 November.